CRISPR/Cas9-Based Transcriptional Activation of Endogenous Myod1 to Reprogram Murine Fibroblasts into Skeletal Myocytes
Conferences
Chakraborty, S; Ji, H; Kabadi, AM; Gersbach, CA; Christoforou, N; Leong, KW
Published in: MOLECULAR THERAPY
May 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 2014
Volume
22
Start / End Page
S215 / S215
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Chakraborty, S., Ji, H., Kabadi, A. M., Gersbach, C. A., Christoforou, N., & Leong, K. W. (2014). CRISPR/Cas9-Based Transcriptional Activation of Endogenous Myod1 to Reprogram Murine Fibroblasts into Skeletal Myocytes. In MOLECULAR THERAPY (Vol. 22, pp. S215–S215).
Chakraborty, Syandan, HaYeun Ji, Ami M. Kabadi, Charles A. Gersbach, Nicolas Christoforou, and Kam W. Leong. “CRISPR/Cas9-Based Transcriptional Activation of Endogenous Myod1 to Reprogram Murine Fibroblasts into Skeletal Myocytes.” In MOLECULAR THERAPY, 22:S215–S215, 2014.
Chakraborty S, Ji H, Kabadi AM, Gersbach CA, Christoforou N, Leong KW. CRISPR/Cas9-Based Transcriptional Activation of Endogenous Myod1 to Reprogram Murine Fibroblasts into Skeletal Myocytes. In: MOLECULAR THERAPY. 2014. p. S215–S215.
Chakraborty, Syandan, et al. “CRISPR/Cas9-Based Transcriptional Activation of Endogenous Myod1 to Reprogram Murine Fibroblasts into Skeletal Myocytes.” MOLECULAR THERAPY, vol. 22, 2014, pp. S215–S215.
Chakraborty S, Ji H, Kabadi AM, Gersbach CA, Christoforou N, Leong KW. CRISPR/Cas9-Based Transcriptional Activation of Endogenous Myod1 to Reprogram Murine Fibroblasts into Skeletal Myocytes. MOLECULAR THERAPY. 2014. p. S215–S215.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 2014
Volume
22
Start / End Page
S215 / S215
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics